Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [525]
News [1474]
Articles [69]
Editorials [2]
Conferences [72]
elearning [5]
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475
Dr Adil I. Daud - University of California San Francisco School of Medicine...
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475 ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014
New antibody-drug conjugate shows early promise against all forms of melanoma
Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
16 Apr 2014
Biomarker development for ipilimumab and prostate GVAX treatment
Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The...
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014
Toll like receptor 7 agonists for cancer immunotherapy
Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany
Toll like receptor 7 agonists for cancer immunotherapy ( Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany )
25 Mar 2014
Adoptive cell therapy of melanoma with autologous tumour infiltrating...
Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen...
Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes ( Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark )
25 Mar 2014
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Reasons for combining immunotherapy with chemo to enhance anti tumour response
Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014
Dendritic cell vaccination combined with CTLA4 blockade
Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium
Dendritic cell vaccination combined with CTLA4 blockade ( Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium )
25 Mar 2014
ecancermedicalscience Editor's Choice for January 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014
Where to next for the elderly with acute myeloid leukaemia?
Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert...
Where to next for the elderly with acute myeloid leukaemia? ( Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands )
19 Dec 2013
2013 ecancermedicalscience article highlights
Prof Gordon McVie - ecancer and European Institute of Oncology
2013 ecancermedicalscience article highlights ( Prof Gordon McVie - ecancer and European Institute of Oncology )
11 Dec 2013
Chimeric antigen receptor produces complete responses and long-term persistence...
Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation